The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France
Basson, Mickael, Ntais, Dionysios, Ayyub, Ruba, Wright, Donna, Lowin, Julia, Chartier, Florence, Roze, Stéphane, Norrbacka, KirsiLanguage:
english
Journal:
Diabetes Therapy
DOI:
10.1007/s13300-017-0321-0
Date:
November, 2017
File:
PDF, 597 KB
english, 2017